13G Filing: Visium Asset Management and Sage Therapeutics, Inc. (SAGE)

Page 11 of 11

Page 11 of 11 SEC Filing


CUSIP No. 78667J108 Page
11
of 11 Pages

Exhibit A

AGREEMENT

The undersigned agree that this Schedule 13G dated February 10, 2016 relating to the Common Stock, $0.0001 par value per share of Sage Therapeutics, Inc.
shall be filed on behalf of the undersigned.

VISIUM ASSET MANAGEMENT, LP
By: JG Asset, LLC, its General Partner
By:

/s/ Mark Gottlieb

Mark Gottlieb
Authorized Signatory
JG ASSET, LLC
By:

/s/ Mark Gottlieb

Mark Gottlieb
Authorized Signatory
JACOB GOTTLIEB
By:

/s/ Mark Gottlieb

Mark Gottlieb
Authorized Signatory

Page 11 of 11 Pages

Follow Sage Therapeutics Inc. (NASDAQ:SAGE)

Page 11 of 11